Search For "fda"
Researchers find drug to correct gene defect that causes immune-driven gut
Updated : 5 years, 5 months ago IST
California [US], September 30 (ANI): A team of researchers found that the drug tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can repair permeability defects in the intestine.
Read More
AliveCor brings the world's only six-lead, FDA-cleared personal ECG to Ind
Updated : 5 years, 5 months ago IST
New Delhi [India] September 25 (ANI/NewsVoir): AliveCor, the global leader in US FDA-cleared personal electrocardiogram (ECG) technology, today announced its entry in the Indian market with the revolutionary launch of the most clinically-validated personal ECG device, KardiaMobile 6L.
Read More
Trump calls FDA plan to tighten guidelines for COVID-19 vaccine approval '
Updated : 5 years, 6 months ago IST
Washington [US], September 24 (ANI/Sputnik): US President Donald Trump ON Wednesday (local time) said that his administration may or may not approve a proposal from the Food and Drug Administration (FDA) that would tighten guidelines for approving a novel coronavirus disease (COVID-19) vacci
Read More
Trump announces emergency authorization of convalescent plasma to treat C
Updated : 5 years, 7 months ago IST
Washington D.C. [US], August 24 (ANI): The US Food and Drug Administration (FDA) has authorised the use of convalescent plasma for the treatment of COVID-19 patients.
Read More
Trump to hold presser concerning 'major therapeutic breakthrough' on coron
Updated : 5 years, 7 months ago IST
Washington DC [US], Aug 23 (ANI): US President Donald Trump will hold a press conference on Sunday concerning a "major therapeutic breakthrough" on coronavirus, the White House said.
Read More
Trump slams FDA for slowing down human trials of COVID-19 vaccine
Updated : 5 years, 7 months ago IST
Washington [US], Aug 23 (ANI): US President Donald Trump on Saturday (local time) slammed the Food and Drug Administration (FDA) for trying to slow down the human trials of coronavirus vaccines.
Read More
US authorises use of saliva test for COVID-19: FDA
Updated : 5 years, 7 months ago IST
Washington [US], August 16 (ANI/Sputnik): The United States' Food and Drug Administration (FDA) has approved a new COVID-19 testing method based on analysing saliva samples.
Read More
Bengaluru organisation gets US FDA, EU nod for device that can kill COVID-
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], Aug 2 (ANI): Bengaluru based Centre for Advanced Research and Development (CARD), the research wing of organisation De scalene has come up with a device called "SHYCOCAN" (Scalene Hypercharge Corona Canon) which neutralizes the coronavirus.
Read More
FDA issues first emergency use authorisation for COVID-19 pool testing
Updated : 5 years, 8 months ago IST
Washington D.C. [USA], July 19 (ANI): The US Food and Drug Administration (FDA) on Saturday (local time) issued an emergency use authorisation (EUA) to Quest Diagnostics that allows pool samples from up to four individuals to test for COVID-19.
Read More
FDA gives directions for using only ICMR-approved diagnostic kits in Goa
Updated : 5 years, 8 months ago IST
Panaji (Goa) [India], July 19 (ANI): Goa Food and Drugs Administration has urged people, chemists, and druggists that rapid diagnostic kits approved by the Indian Council of Medical Research and DCGI must be used.
Read More
Indian pharma compliance standards improving, regulatory risks here to sta
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More